Drugs targeting at cancer stem cells

Bloomberg news today reported that a group at MIT and Broad found "The compound, salinomycin, reduced the number of cancer stem cells100 times more than did Bristol-Myers Squibb Co.’s Taxol, a common chemotherapy medicine, according to a report published yesterday in the journal Cell." [link]

The original contribution (paper) was published in Cell, and the corresponding authors include, Piyush B. Gupta (also first author), Robert A. Weinberg and Eric S. Lander. [Abstract]

More info regarding solinomycin could be found at wikipedia. [link]

Read more!